Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewGastroenterologyImmunology Open Access | 10.1172/jci.insight.195354

Shared CD4+ T cell receptor specificity groups in Crohn’s disease and ulcerative colitis

Joshua E. Chan,1 Azam Mohsin,1 Jens Krijgsman,2 Ciska Lindelauf,2 Qinghui Mu,3 Brianna Cavalla,4 Xuhuai Ji,5 Sarah E. Streett,4 Vincent van Unen,6 and Mark M. Davis1

1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America

2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands

3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America

4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America

5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America

6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America

Find articles by Chan, J. in: PubMed | Google Scholar

1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America

2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands

3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America

4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America

5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America

6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America

Find articles by Mohsin, A. in: PubMed | Google Scholar

1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America

2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands

3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America

4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America

5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America

6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America

Find articles by Krijgsman, J. in: PubMed | Google Scholar

1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America

2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands

3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America

4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America

5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America

6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America

Find articles by Lindelauf, C. in: PubMed | Google Scholar

1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America

2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands

3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America

4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America

5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America

6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America

Find articles by Mu, Q. in: PubMed | Google Scholar

1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America

2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands

3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America

4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America

5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America

6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America

Find articles by Cavalla, B. in: PubMed | Google Scholar

1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America

2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands

3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America

4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America

5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America

6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America

Find articles by Ji, X. in: PubMed | Google Scholar

1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America

2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands

3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America

4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America

5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America

6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America

Find articles by Streett, S. in: PubMed | Google Scholar

1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America

2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands

3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America

4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America

5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America

6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America

Find articles by van Unen, V. in: PubMed | Google Scholar |

1Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States of America

2Department of Immunology, Leiden University Medical Center, Leiden, Netherlands

3Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, United States of America

4Department of Gastroenterology and Hepatology, Stanford University School of Medicine, Stanford, United States of America

5Human Immune Monitoring Center, Stanford University School of Medicine, Stanford, United States of America

6Institute of Immunity, Transplantation and Infection, Stanford University School of Medicine, Stanford, United States of America

Find articles by Davis, M. in: PubMed | Google Scholar

Published June 9, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.195354.
Copyright © 2026, Chan et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published June 9, 2026 - Version history
View PDF
Abstract

Inflammatory bowel disease (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), is marked by chronic intestinal inflammation and dysregulated immunity. Although UC and CD affect different areas of the gastrointestinal tract, both diseases share aberrant CD4+ memory T cell responses, with HLA-DRB1 as a major genetic risk factor. HLA-DRB1 encodes MHC class II molecules that influence the CD4+ T cell receptor (TCR) repertoire, yet how these genotypes shape TCR specificity in IBD remains unclear. Here, we genotyped HLA-DRB1 and profiled 3.13 million TCRb sequences from circulating memory CD4+ T cells in 33 IBD patients (20 UC, 13 CD) and 14 healthy controls. Using the GLIPH2 algorithm, we distilled 468,441 candidates based on CDR3 amino acid motifs into 440 high-confidence TCR specificity groups significantly enriched among individuals sharing HLA-DRB1 alleles. Notably, five specificity groups were IBD-enriched and shared between UC and CD, suggesting common antigen targets in both diseases. We also observed increased frequencies of clonally expanded cytotoxic GZMB+PRF1+ memory CD4+ T cells and KIRs+CD8+ T cells in a subset of risk-allele carriers with IBD. These findings elucidate distinct, HLA-linked TCR specificity groups in IBD and provide mechanistic insights that may advance antigen discovery and personalized medicine.

Graphical Abstract
graphical abstract
Supplemental material

View All Supplementary Figures and Tables

View

Version history
  • Version 1 (June 9, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts